Skip to main content
OpenTrials
Completed

NCT Number: NCT01406834

Treatment for the Mental Health Impact of Killing in War

The goal of this project is to test the feasibility, acceptability, and efficacy of a treatment module addressing the mental health and functional impact of killing in the war zone.

The investigators will enroll between 12-20 Veterans who have killed in war and have been diagnosed with post-traumatic stress disorder (PTSD) for a pilot study assessing the efficacy of the six-session treatment. Veterans will be randomized either to the treatment or to the waitlist control group.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

San Francisco VA Medical Center

San Francisco, California, 94121, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of PTSD
  • Veteran will need to endorse having taken another life in a war zone context
  • Have received some prior evidence-based treatment for PTSD

Exclusion criteria

  • Meet current or lifetime criteria for a psychotic disorder
  • Participants in current PTSD treatment will not be excluded;however,if receiving medications they will need to be stabilized on current medications for at least one month.
  • If receiving Prolonged Exposure Therapy or Cognitive Behavioral Therapy, individuals will need to wait two weeks after they have completed the treatment to enroll in the study.

Treatment and study plan

Impact of Killing CBT Treatment

Behavioral

Treatment will include six, one hours sessions with a licensed clinical psychologist or an advanced postdoctoral fellow under the close supervision of a licensed psychologist.

Primary outcomes

  1. Change in psychological symptoms as measured by the Symptom Checklist-90 (SCL-90-R)

    Time frame: Measured at baseline and study completion (week 7)

    A brief multidimensional self-report inventory that screens for nine symptoms of psychopathology and provides three global distress indicators.

Secondary outcomes

  1. Change in killing-related maladaptive cognitions as measured by the Killing Cognitions Scale (KCS)

    Time frame: Measured at baseline and study completion (week 7)

    Assesses killing-related maladaptive cognitions

Sponsors and collaborators

Lead sponsor

University of California, San Francisco

Other

Collaborators

  • US Department of Veterans Affairs

Registry information

Official study title

Treatment for the Mental Health Impact of Killing in War: Augmentation of Existing Evidence-Based Mental Health Interventions

Important dates

Study start
2011
Primary completion
2013
Study completion
2013
First posted
Aug 1, 2011
Registry last updated
Aug 18, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.